Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply
暂无分享,去创建一个
[1] M. Merli,et al. Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis , 2018, Alimentary pharmacology & therapeutics.
[2] D. Bauer,et al. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity , 2018, Alimentary pharmacology & therapeutics.
[3] C. Crescioli,et al. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. , 2017, Journal of hepatology.
[4] M. Rudler,et al. A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis , 2017 .
[5] D. Christodoulou,et al. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. , 2016, Journal of hepatology.
[6] J. Bosch,et al. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. , 2016, Gastroenterology.
[7] R. Moreau,et al. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. , 2015, Journal of hepatology.
[8] M. Kiehntopf,et al. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[9] F. Lammert,et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. , 2013, Journal of hepatology.
[10] D. Valla,et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.
[11] J. Bosch,et al. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension , 2011, Gut.
[12] L. Blendis,et al. Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension , 1995, Hepatology.